SOW
VIR icon

State of Wyoming’s Vir Biotechnology VIR Stock Holding History

State of Wyoming’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,287
Closed -$83.9K – 1883
2024
Q1 		$83.9K Buy
8,287
+168
+2% +$1.71K 0.01% 1113
2023
Q4 		$81.7K Buy
8,119
+5,292
+187% +$48.4K 0.02% 1140
2023
Q3 		$26.5K Buy
2,827
+2,719
+2,518% +$38.8K 0.01% 1470
2023
Q2 		$2.65K Sell
108
-7,398
-99% -$186K ﹤0.01% 1500
2023
Q1 		$175K Sell
7,506
-2,455
-25% -$62.8K 0.06% 428
2022
Q4 		$252K Buy
9,961
+4,908
+97% +$120K 0.08% 198
2022
Q3 		$97K Buy
5,053
+2,316
+85% +$58.9K 0.05% 613
2022
Q2 		$70K Buy
+2,737
New +$63.9K 0.04% 731

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of Wyoming's VIR Position: Q2 2024 in Review

State of Wyoming sold out of Vir Biotechnology (VIR) in Q2 2024, closing a stake of 8,287 shares — an estimated $83.9K sold.

State of Wyoming first reported a position in VIR in Q2 2022 and held it in 8 quarters. The position peaked at $252K in Q4 2022. 215 funds tracked by Wall St. Rank hold VIR as of Q2 2024.

  • State of Wyoming reported no remaining Vir Biotechnology position as of Q2 2024 after selling out during the quarter.
  • State of Wyoming sold 8,287 Vir Biotechnology shares in Q2 2024, an estimated $83.9K.
  • State of Wyoming first reported a position in Vir Biotechnology in Q2 2022 and held it in 8 quarters.
  • State of Wyoming's Vir Biotechnology position peaked at $252K in Q4 2022.
  • 215 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2024.

Based on State of Wyoming's 13F filing for Q2 2024, filed 14 Aug 2024.